Common [[adverse drug reaction]]s (ADRs) associated with the use of dicloxacillin include: [[diarrhoea]], [[nausea]], [[rash]], [[urticaria]], [[pain]] and [[inflammation]] at injection site, [[superinfection]] (including [[candidiasis]]), [[allergy]], and transient increases in liver enzymes and bilirubin.<ref name=":1" />

 


 
On rare occasions, [[cholestasis|cholestatic jaundice]] (also referred to as cholestatic hepatitis) has been associated with dicloxacillin therapy. The reaction may occur up to several weeks after treatment has stopped, and takes weeks to resolve. The estimated incidence is 1 in 15,000 exposures, and is more frequent in people over 55 years old, females, and those with treatment longer than 2 weeks.<ref name=":1" />

 


 
It should be used with caution and monitored in the elderly, particularly with intravenous administration, due to a risk of [[thrombophlebitis]].<ref name=":0" />

 

